# IMT

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/imt

- Industry: Medical Devices & Equipment
- Headquarters: Gwangju, South Korea
- Website: www.imeditech.kr/
- Latest round: Series B (Jul 20, 2026)
- Investors on record: 9

## About

Based in South Korea, Imeditech Co., Ltd., doing business as IMT Inc. operates in the medical device sector, focusing on advanced technologies that enhance patient care and medical outcomes.Imeditech Co., Ltd. specializes in the development and manufacturing of medical devices. Founded in 2023 in Gwangju, South Korea, the company has completed one deal as of June 10, 2025. The founder's previous history is not specified. The company has not undergone any known changes in business strategy or structure.Imeditech specializes in the development, manufacturing, and distribution of advanced medical devices aimed at enhancing patient care and outcomes. The company offers a range of innovative products, including nanotechnology-based artificial blood vessels, vascular stents, non-vascular covered stents, cardiovascular stents, drug-eluting balloon catheters, and negative pressure wound dressings. These products are designed to address critical medical challenges, such as vascular diseases and wound healing, thereby serving hospitals, clinics, and healthcare providers globally. Imeditech primarily markets its products in regions such as Europe, North America, and Asia, catering to a diverse client base that includes healthcare professionals and institutions dedicated to improving patient health.The revenue model for Imeditech is structured around direct sales to healthcare institutions and professionals, with a focus on B2B transactions. The company engages in partnerships with hospitals and clinics to supply its flagship products, such as the TIGERTRIEVER™ and COMANECI™ devices, which are known for their innovative technology and high-quality standards. Transactions typically involve bulk orders, where clients procure products based on their specific medical needs and patient volumes. Pricing plans for these medical devices are tailored to ensure accessibility while reflecting the advanced technology and efficacy of the offerings, thereby facilitating high-volume sales and fostering long-term relationships with healthcare providers.In June 2025, Imeditech Co., Ltd. raised an undisclosed amount of Series A funding from new investors Korea Investment Partners, NAU IB Capital, and Platinum Technology Investment. The company plans to utilize this funding to improve its Good Manufacturing Practices standards, prepare for US Food and Drug Administration certification, and conduct international clinical trials. Additionally, Imeditech aims to expand into new markets with a focus on increasing its presence in regions such as North America and Europe by 2026, as they launch new products designed to tackle unmet medical needs. In July 2026, IMT Inc. raised an undisclosed amount in series B funding from new investors Korea Investment & Securities, Industrial Bank of Korea, and Vine Ventures. Returning investors Korea Investment Partners, NAU IB Capital, Sunbo Angel Partners, Korea Credit Guarantee Fund, and Banks Foundation for Young Entrepreneurs also participated in this round.

The company will use the July 2026 funding to accelerate and fully launch its expansion into the global market.

## Funding rounds

- Series B, Jul 20, 2026 — Korea Investment & Securities, Industrial Bank of Korea, Korea Investment Partners, Banks Foundation for Young Entrepreneurs, NAU IB Capital, Korea Credit Guarantee Fund, Sunbo Angel Partners, Vine Ventures
- Series A, Jun 10, 2025 — Korea Investment Partners, NAU IB Capital, Platinum Technology Investment

## Investors

- Korea Investment Partners (https://capitalatlas.ai/funds/korea-investment-partners) — Series A, Series B
- NAU IB Capital (https://capitalatlas.ai/funds/nau-ib-capital) — Series A, Series B
- Platinum Technology Investment (https://capitalatlas.ai/funds/platinum-technology-investment) — Series A
- Korea Investment & Securities (https://capitalatlas.ai/funds/korea-investment-securities) — Series B
- Industrial Bank of Korea — Series B
- Banks Foundation for Young Entrepreneurs — Series B
- Korea Credit Guarantee Fund — Series B
- Sunbo Angel Partners (https://capitalatlas.ai/funds/sunbo-angel-partners) — Series B
- Vine Ventures — Series B